Literature DB >> 7787338

Secondary gain concept: a review of the scientific evidence.

D A Fishbain1, H L Rosomoff, R B Cutler, R S Rosomoff.   

Abstract

UNLABELLED: The "secondary gain" concept originated in the psychoanalytic literature, where it was never vigorously examined. The purpose of this review is to determine if there are scientific studies that have explored the validity of this concept.
DESIGN: A computer and manual literature review yielded 166 references in which primary, secondary, and tertiary gain were mentioned. Twenty-four (14.5%) of these reports were "secondary gain" studies. Fourteen "reinforcement" studies were also found. These 38 studies were grouped according to topics and reviewed in detail.
SETTING: Any medical treatment setting including pain treatment was utilized in the review procedure, i.e., no exclusion criteria. PATIENTS: Any patient type, including those suffering from chronic pain, were utilized in the review procedure, i.e., no exclusion criteria.
RESULTS: A significant but limited number of studies have investigated the "secondary gain" concept, and the results of some of these studies are in conflict. Results of some studies, however, are remarkably consistent in supporting the importance of "secondary gain" to behavior. Some studies have methodological flaws, usually relating to how the presence of secondary gain was established.
CONCLUSIONS: Overall the results of the reviewed studies support the potential importance of the "secondary gain" concept to understanding illness behavior and underscore a need for future research in this area.

Entities:  

Mesh:

Year:  1995        PMID: 7787338

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  10 in total

1.  Social consequences of children's pain: when do they encourage symptom maintenance?

Authors:  Lynn S Walker; Robyn Lewis Claar; Judy Garber
Journal:  J Pediatr Psychol       Date:  2002-12

2.  Heterogeneous depression responses to chronic pain onset among middle-aged adults: a prospective study.

Authors:  Zhuoying Zhu; Isaac R Galatzer-Levy; George A Bonanno
Journal:  Psychiatry Res       Date:  2014-03-11       Impact factor: 3.222

3.  The relation between upper extremity joint involvement and grip force in early rheumatoid arthritis: a retrospective study.

Authors:  Maria Rydholm; Ingegerd Wikström; Sofia Hagel; Lennart T H Jacobsson; Carl Turesson
Journal:  Rheumatol Int       Date:  2019-09-07       Impact factor: 2.631

Review 4.  Addressing the intersecting problems of opioid misuse and chronic pain treatment.

Authors:  Richard A Denisco; Redonna K Chandler; Wilson M Compton
Journal:  Exp Clin Psychopharmacol       Date:  2008-10       Impact factor: 3.157

5.  Halo and spillover effect illustrations for selected beneficial medical devices and drugs.

Authors:  Brent D Kerger; Autumn Bernal; Dennis J Paustenbach; Gavin Huntley-Fenner
Journal:  BMC Public Health       Date:  2016-09-15       Impact factor: 3.295

6.  Injured workers' perception of loss and gain in the return to work process.

Authors:  Hon Sun Lai; Grace Py Szeto; Chetwyn Ch Chan
Journal:  Risk Manag Healthc Policy       Date:  2017-02-07

7.  Whiplash Syndrome Reloaded: Digital Echoes of Whiplash Syndrome in the European Internet Search Engine Context.

Authors:  Michael Noll-Hussong
Journal:  JMIR Public Health Surveill       Date:  2017-03-27

8.  A Framework for Understanding the Role of Psychological Processes in Disease Development, Maintenance, and Treatment: The 3P-Disease Model.

Authors:  Casey D Wright; Alaina G Tiani; Amber L Billingsley; Shari A Steinman; Kevin T Larkin; Daniel W McNeil
Journal:  Front Psychol       Date:  2019-11-20

Review 9.  Population Modelling in Affective Disorders.

Authors:  Erdem Pulcu
Journal:  Curr Behav Neurosci Rep       Date:  2021-04-15

10.  Dissociative stupor, mutism and amnesia in a young man.

Authors:  R R Jayaprakash; A P Rajkumar; M Nandyal; S Kurian; K S Jacob
Journal:  Indian J Psychiatry       Date:  2012-04       Impact factor: 1.759

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.